Penel, N., Glabbeke, M. V., Mathoulin-Pelissier, S., Judson, I., Sleijfer, S., Bui, B., . . . Blay, J. (2011). Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: The European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study. British journal of cancer, 104(10), . https://doi.org/10.1038/bjc.2011.136
Chicago-Zitierstil (17. Ausg.)Penel, Nicolas, et al. "Performance Status Is the Most Powerful Risk Factor for Early Death Among Patients with Advanced Soft Tissue Sarcoma: The European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) Study." British Journal of Cancer 104, no. 10 (2011). https://doi.org/10.1038/bjc.2011.136.
MLA-Zitierstil (9. Ausg.)Penel, Nicolas, et al. "Performance Status Is the Most Powerful Risk Factor for Early Death Among Patients with Advanced Soft Tissue Sarcoma: The European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) Study." British Journal of Cancer, vol. 104, no. 10, 2011, https://doi.org/10.1038/bjc.2011.136.